Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940544 | PMC |
http://dx.doi.org/10.1155/2016/8737082 | DOI Listing |
Am J Ophthalmol
January 2025
PharmaLogic Development, Inc., San Rafael CA; Department of Ophthalmology & Vision Science, University of California, Davis, School of Medicine. Electronic address:
Am J Ophthalmol
January 2025
University of California, Irvine Gavin Herbert Eye Institute; Irvine, CA, USA.
JAMA Ophthalmol
January 2025
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
Importance: In-office suprachoroidal viscopexy (SCVEXY) is a relatively new procedure for rhegmatogenous retinal detachment (RRD), but minimal information is available regarding outcomes and safety.
Objective: To report outcomes with in-office SCVEXY for primary acute RRD.
Design, Setting, And Participants: This retrospective case series was conducted at St Michael's Hospital in Toronto, Ontario, Canada from June 2023 to February 2024 among consecutive patients with primary acute RRDs who presented with retinal tears that were reachable with the current in-office SCVEXY technique in the temporal or nasal retina.
Am J Ophthalmol
November 2024
Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address:
Am J Ophthalmol
November 2024
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Study Center for Ocular Diseases, Guangzhou, China. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!